State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment

Journal of Gastrointestinal Oncology

Michael D. Chuong¹  Seth Kligerman³  Payam Sajedi³  Mohan Suntharalingam¹  Rakhi Goel²  Jolinta Lin¹ 

[1] Department of Radiation Oncology,University of Maryland Medical Systems, Baltimore, USADepartment of Radiation Oncology,University of Maryland Medical Systems, Baltimore, USADepartment of Radiation Oncology,University of Maryland Medical Systems, Baltimore, USA;Department of Diagnostic Imaging, Baltimore Veterans Affairs Medical Center, Baltimore, USADepartment of Diagnostic Imaging, Baltimore Veterans Affairs Medical Center, Baltimore, USADepartment of Diagnostic Imaging, Baltimore Veterans Affairs Medical Center, Baltimore, USA;Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland Medical Systems, Baltimore, USADepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland Medical Systems, Baltimore, USADepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland Medical Systems, Baltimore, USA

关键词: Positron emission tomography (PET);    esophageal cancer;    molecular imaging;    neoadjuvant therapy;   

DOI  :  10.3978/j.issn.2078-6891.2014.062

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown